Projekt

Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination with Pembrolizumab Versus Investigator’s Choice in HLA-A*02:01-positive Participants with Previously Treated Advanced Melanoma (TEBE-AM)

Laufend - Rekrutierung – laufend · 2024 bis 2027

Scherrer Julia, Aeppli Stefanie, Quinter Janine